Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Resistant starch (RS2/RS3)

Resistant Starch (RS2 / Green Banana / Potato) · also known as Resistant starch, Raw potato starch, Green banana flour, RS2

Resistant starch is not digested in the small intestine. In the colon, gut bacteria can ferment it into short-chain fatty acids such as butyrate. Human studies can detect higher fecal butyrate, but individual differences are large. There is not yet consistent human evidence that it improves tight junctions or insulin sensitivity.

Typical dose: Products are usually taken at 10–30 g/day, mixed into lukewarm water, yogurt or a meal replacement. The resistant starch content on the label is not the same as the total product weight. Acid production and bacterial responses also vary with starch type, dose and individual gut flora.
Absorption and forms: Heating changes the structure of resistant starch, but cooling can produce retrograded RS3, so it should not be assumed that everything loses its fermentability once it goes above 40°C. It is best to start with a small dose (for example 5–10 g) and increase gradually.

Clinical uses and human evidence

Blood sugar and insulin resistance

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Pugh 2023 · Front Nutr · Meta-analysis · n=982 — A comparison of the effects of resistant starch types on glycemic response in individuals with type 2 diabetes or prediabetes: A systematic review and meta-analysis
  2. Peterson 2018 · Am J Clin Nutr · RCT · n=68 — Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial

Fatty liver and liver enzymes

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Ni 2023 · Cell Metab · RCT · n=200 — Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
  2. Peterson 2018 · Am J Clin Nutr · RCT · n=68 — Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial

Body weight and body fat

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Li 2024 · Nat Metab · Randomized crossover trial · n=37 — Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota
  2. Lin 2025 · Front Nutr · Meta-analysis · n=1073 — Effects of resistant starch consumption on anthropometric and serum parameters in adults with metabolic syndrome-related risks: a systematic review and meta-analysis

High LDL cholesterol

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Lin 2025 · Front Nutr · Meta-analysis · n=1073 — Effects of resistant starch consumption on anthropometric and serum parameters in adults with metabolic syndrome-related risks: a systematic review and meta-analysis

Constipation

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Bush 2023 · Nutrients · RCT · n=75 — Consumption of Solnul(™) Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial

Mechanisms of action

Colonic short-chain fatty acid (SCFA/butyrate) fermentation substrate and receptor activation

★★★★★Mechanism evidence: grade A

Resistant starch is not digested in the small intestine and is fermented by colonic bacteria, making it a substrate for short-chain fatty acids such as butyrate. In human studies, a high-resistant-starch diet can increase fecal butyrate concentration, but individual differences are large, and the degree of receptor activation cannot be inferred directly from fecal concentration.

References (2)
  1. Phillips et al. 1995 · 11-person randomized crossover dietary trial: a high-resistant-starch diet increased fecal butyrate concentration and excretion
  2. 2016 human intervention study · Fecal butyrate responses to raw potato starch varied markedly between individuals

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

Evidence for improved tight junctions comes mainly from diabetic mouse studies. Butyrate can fuel the colonic epithelium, but a randomized crossover trial in people with metabolic syndrome did not show a clear improvement in permeability, and junction protein changes in humans have not been confirmed.

References (2)
  1. Snelson et al. 2024 · Diabetic mouse study: resistant starch altered the intestinal barrier and some tight junction-related markers
  2. 2022 randomized crossover trial in people with metabolic syndrome · A potato diet containing resistant starch did not show a clear improvement in permeability

Safety and drug interactions

People with severe small intestinal bacterial overgrowth (SIBO) who take large amounts before antibacterial treatment may experience more bloating and flatulence. Starting with a very small amount to test tolerance is recommended.
Open in the interactive app ›